• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC OCTARAY, GALAXY, 48P, 3-3-3-3-3, F-CURVE; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC OCTARAY, GALAXY, 48P, 3-3-3-3-3, F-CURVE; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY Back to Search Results
Model Number D160906
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Cardiac Arrest (1762)
Event Date 04/06/2023
Event Type  Death  
Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Note: field b2.Date of death was not provide therefore it was populated with (b)(6) 2023 since it was stated the event was (b)(6) 2023 and the patient passed away 24 hours later.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a patient underwent a ischemic ventricular tachycardia (isvt) ¿ left ablation procedure with a octaray, galaxy, 48p, 3-3-3-3-3, f-curve and the patient suffered cardiac arrest requiring surgical intervention and prolonged hospitalization and ultimately death.It was reported that after starting to map the left ventricle, the patient went into emd (electromechanical dissociation) and it was observed by intra-cardiac echo that there was no cardiac movement.A code was called and the patient was resuscitated successfully.An impella device was inserted and the patient was stabilized and transferred to the intensive care unit (icu).Additional information received indicates the adverse event was discovered during use of bwi products, ~1 minute after entering the left ventricle with the octraray.Physician¿s opinion on the cause of this adverse event is that it was patient condition related.Post cabg patient with low ejection fraction (ef).Patient was unstable.Intervention provided was that a code was called.Cardio pulmonary resuscitation (cpr) was administered followed by emergent impella.Patient underwent a stemi 8 hours post impella implant.Patient could not stabilize and condition worsened.Family signed dnr and the patient passed 24 hours later after initial code was called.Patient required extended hospitalization because of the adverse event as patient was transferred to icu before passing 24 hours later.
 
Manufacturer Narrative
It was reported that a patient underwent a ischemic ventricular tachycardia (isvt) ¿ left ablation procedure with a octaray, galaxy, 48p, 3-3-3-3-3, f-curve and the patient suffered cardiac arrest requiring surgical intervention and prolonged hospitalization and ultimately death.It was reported that after starting to map the left ventricle, the patient went into emd (electromechanical dissociation) and it was observed by intra-cardiac echo that there was no cardiac movement.A code was called and the patient was resuscitated successfully.An impella device was inserted and the patient was stabilized and transferred to the intensive care unit (icu).Patient required extended hospitalization because of the adverse event as patient was transferred to icu before passing 24 hours later.Device evaluation details: on 16-may-2023, the product was returned to biosense webster inc (bwi) for evaluation.The evaluation has been completed.A visual inspection and revision of all features were performed following bwi procedures.Visual analysis revealed no damage or anomalies on the device.The device features were reviewed, and no issues were observed during the product investigation.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.No malfunction was observed during the product analysis.The physician¿s opinion on the cause of this adverse event is that it was patient's condition: post-cabg patient with low ef.The patient was unstable the root cause of the adverse event remains unknown.In addition, no device malfunction was reported, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.The instruction for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OCTARAY, GALAXY, 48P, 3-3-3-3-3, F-CURVE
Type of Device
CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key16866010
MDR Text Key314524175
Report Number2029046-2023-00956
Device Sequence Number1
Product Code MTD
UDI-Device Identifier10846835021134
UDI-Public10846835021134
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193237
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD160906
Device Catalogue NumberD160906
Device Lot Number30932702L
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/16/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SMARTABLATE GENERATOR SPARE-US
Patient Outcome(s) Death;
Patient Age79 YR
Patient SexMale
Patient Weight113 KG
-
-